Several of Vision Eye Institute’s cataract and refractive surgeons (A/Prof Lawless, Dr Reich, Dr Levitz, Dr Bhatt, A/Prof Roberts) and their colleagues recently published patient outcomes for the new Alcon IQ Panoptix intraocular lens (IOL) in Eye and Vision.
The trifocal IOL is designed to correct age-related short-sightedness (presbyopia) and provide clear vision at near, intermediate and far distances, offering spectacle independence for some people after cataract surgery or refractive lens exchange.
Thirty-three patients were included in the study, all of whom wanted to gain spectacle independence with their choice of IOL.
The main findings of the study were:
The authors concluded that this IOL appears to provide safety and visual profiles similar to other trifocal IOLs, without significant post-operative visual symptoms.
Finally, they emphasised the importance of patients having an in-depth discussion with their surgeon about their motivations, working and reading requirements before selecting their IOL, to optimise patient satisfaction.
You can read the full study here.
IMPORTANT: If you are concerned about your eyes and require an urgent consultation, DO NOT use this form. Please call one of our clinics during office hours or contact your nearest emergency department.